In Memoriam Sigalit Ariely-Portnoy, Ph.D

CEO and Founder

Dr. Ariely-Portnoy passed away suddenly on June 16, 2024. She left behind an amazing and dedicated team that will continue her spirit and work. Dr. Ariely-Portnoy had many years of experience in the pharmaceutical industry (15 years at Taro and Teva and 9 years at Gsap) and was very well acquainted with pharmaceutical processes, change management processes, and the building of production plants. Her role at Taro was SVP for operations in Israel, and at Teva, she was the OSD plant manager, responsible for more than 1,000 production employees and annual sales of $2.4 billion.

Dr. Ariely-Portnoy served as President of the Israeli Chapter of the Parenteral Drug Association (PDA) from 2003 to 2006.

In 2009, Dr. Ariely-Portnoy founded Gsap, which provides regulatory, clinical, quality, and validation services to pharmaceutical, biotechnology, cell therapy, and medical device companies as well as hospitals. In this role, she successfully led hundreds of regulatory audits by the Israeli MoH, the FDA, the EMA, and various Notified Bodies. Under her management, Gsap executed dozens of regulatory submissions for innovative drugs and devices.

Sigalit was the force that brought the entire Gsap staff to lead processes with their clients to achieve their goals and in her spirit, will continue to do so.